| Product Information |
|
| Registration Number |
DR-XY48660
|
| Generic Name |
Dolutegravir (as sodium) + Lamivudine + Tenofovir
disoproxil fumarate
|
| Brand Name |
None
|
| Dosage Strength |
50 mg/300 mg/300 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
White opaque round HDPE bottle with white opaque PP child-resistant closure and silica gel sachet as desiccant x 30 tablets (Box of 30 tablets)
|
| Manufacturer |
Aurobindo Pharma Limited (Unit VII)
|
| Country of Origin |
|
| Trader |
India
|
| Importer |
N/A
|
| Distributor |
S.M.H.P. Marketing & Consultancy
|
| Application Type |
Monitored Release (Re-application)
|
| Issuance Date |
21 March 2023
|
| Expiry Date |
21 March 2026
|